1 / 24

Vertebral PTA: Indications and Technique

Vertebral PTA: Indications and Technique. Patrick L. Whitlow, MD Director, Interventional Cardiology The Cleveland Clinic Foundation. I have NO relationships related to this presentation. Off label use of products will be discussed in this presentation. .

barbra
Download Presentation

Vertebral PTA: Indications and Technique

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Vertebral PTA:Indications and Technique Patrick L. Whitlow, MD Director, Interventional Cardiology The Cleveland Clinic Foundation I have NO relationships related to this presentation.Off label use of products will be discussed in this presentation.

  2. Vertebral Artery Stenosis/Occlusion: Symptoms • 50% present with stroke as 1st symptom • Embolic: sudden maximum onset, blurred vision, or homonymous hemianopsia- usually originate from VA origin • Vertebrobasilar TIA’s - 22-35% stroke by 5yrs, and mortality with CVA 20-30%

  3. Vertebral Artery Stenosis/Occlusion: Symptoms • Hemodynamic: tandem/severe lesions Multiple Symptoms: vertigo,nausea, visual dysfunction; perioral paresthesia; ataxia; dysarthria; syncope; headache; nystagmus; facial palsy,numbness • Thrombotic: prolonged, fluctuating course to maximum neurologic deficit or coma

  4. Vertebral Artery Stenosis/Occlusion: Symptoms • Symptoms: Hemodynamic Thrombotic • Predominantly occur in Patients with Multi-Vessel Disease because of Redundant Blood Supply • Emboli may occur with isolated disease

  5. Vertebral Artery Stenosis/Occlusion: Treatment Symptomatic  angiography > revascularization Asymptomatic  majority get medical rx Consider revascularization if high risk for CVA (Remember 50% of these have no warning TIA’s) > 70% stenosis, esp. if worsening and dominant or single vertebral Posterior hypoperfusion or decreased reserve

  6. Vertebral Artery Stenosis/ Occlusion: Treatment Traditional: Avoid Hypotension;use Antiplatelet or Anticoagulant; carotid duplex; IC Doppler Vertebral Origin Lesions difficult to quantify w/o angiography, and need to assess collaterals >Consider surgery for V1 disease(unusual) >Consider percutaneous intervention

  7. Background • Limited data exists on percutaneous treatment of symptomatic vertebral artery disease • Surgical treatment for symptomatic vertebral artery disease has significant morbidity and is limited to V1 segment

  8. 4 3 2 1

  9. Vertebral Artery Disease:Surgery for V1 Segment • Carotid-Vertebral Transpositionor Endarterectomy • Mortality > 4% • Morbidity 10-20%

  10. Vertebral Surgery Complications of V1 Surgery: Transient ischemic attack 2.2% Thrombosis 8.7% Koskas,Ann Vasc Surg 9:515-524 Recurrent laryngeal nerve palsy 2% Horner’s syndrome 15% Lymphocele 4% Chylothorax 0.5% Thrombosis 1% Beurger, Long Term Results in Vascular Surgery 1993:69-79

  11. Vertebral Artery Stenosis / Occlusion: Treatment • No randomized studies Meds vs Surgery and No Trials Intervention vs either Meds or Surgery • Symptoms are frequently vague: may need flow study to determine significance Neuro Consult very helpful

  12. Vertebral Artery Angiography Baseline Angiography: 30-45% LAO Arch Angio with 4 vessel study to define collateral support of the posterior circulation( non-selective) For Selective vertebral: JR4,Berenstein , MP A-P ; 20-30o contralateral oblique;cranial 20º

  13. Vertebral Artery Stenting • Pretreat with ASA, Clopidogrel > 3 days • Access Femoral Artery, or Radial / Brachial • JR4, IMA, MP, H1, 6Fr Guide or /Ansel Sheath • Heparin 50-70 units/kg: ACT 240-300 seconds • Rarely consider IIb/IIIa blocker (IC Hemorrhage) • Consider Embolic Protection: Tortuosity, landing zone, branches, retrieval

  14. Vertebral Artery Stenting • Consider subclavian “Buddy-Wire” • Roadmap; cross with 0.014” wire or EPD - stay out of Branches • Consider predilation with coronary balloonvs direct stent • Artery size 2.7 - 5.5mm, mean 4.5mm; lesion length typically 5-10mm - so use coronary stents

  15. Vertebral Artery Stenting • If ostial, use balloon expandable stent for precise placement ~2mm into subclavian origin • High restenosis rates in some series(up to 43%) - ?ostial coverage, ?recoil • Consider DES; stents with radial force

  16. Vertebral Artery Stenting • Precise Deployment, slow inflation to ~8atm • Pull balloon back high pressure (12-14atm) to minimize risk distal dissection, Flare edge • Nitro and angio to assess size, edges

  17. Vertebral Artery Stenting • Optimize stent size with post-dilation • Frequent Neuro status checks • Final angios to asses for embolization, EPD damage ,wire trauma,kinking • Esp with EPD, push/pull guide into stent for retrieval

  18. Vertebral Artery Stenting • Usual post Sheath care • Usual ASA, Plavix • Independent Neuro Exam • Monitor overnight • Usual Risk Factor Control

  19. Vertebral Artery Stenting Results • 94-100% Technical Success • Complications: Dissection, spasm, embolism, CVA, TIA, thrombosis, IC bleeding - All rare • Usual 1-2% sheath related events

  20. Vertebral Artery StentingFollow-Up • Work with a Neurologist • Non-invasive assessment not reliable • Consider Re-Angio 4-6 months • Restenosis 10-43% - usually asymptomatic • Randomized Trials, long term follow-up are needed!! ?Role of EPD, DES, surgery

  21. Severe Ostial Vertebral Stenosis Post-procedure Pre-procedure

More Related